683 results on '"Ayers, Colby R."'
Search Results
52. Association of Health Aging and Body Composition (ABC) Heart Failure score with cardiac structural and functional abnormalities in young individuals
53. Corrigendum to U.S. Population at Increased Risk of Severe Illness from COVID-19
54. U.S. population at increased risk of severe illness from COVID-19
55. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study)
56. Identifying Discordance of Right- and Left-Ventricular Filling Pressures in Patients with Heart Failure by the Clinical Examination
57. Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial
58. Discordance Between Severity of Heart Failure as Determined by Patient Report Versus Cardiopulmonary Exercise Testing
59. Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study
60. Association of 3.0-T Brain Magnetic Resonance Imaging Biomarkers With Cognitive Function in the Dallas Heart Study
61. HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
62. The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
63. Association of troponin T detected with a highly sensitive assay and cardiac stricture and mortality risk in the general population
64. Variation of heart transplant rates in the United States during holidays
65. Effect of Normal Aging Versus Hypertension, Abnormal Body Mass Index, and Diabetes Mellitus on White Matter Hyperintensity Volume
66. Glycated Hemoglobin in 14,850 Adolescent Blood Donors: A Pilot Screening Program
67. The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study
68. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
69. Tolerability of sirolimus: a decade of experience at a single cardiac transplant center
70. Systematic method for cleaning circumferential strain from raw harmonic phase magnetic resonance imaging (HARP) analyzed data
71. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
72. Feasibility of Remote Video Assessment of Jugular Venous Pressure and Implications for Telehealth
73. Discordant effects of rosiglitazone on novel inflammatory biomarkers
74. Left atrial structure and function and clinical outcomes in the general population
75. Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients
76. Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
77. The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: Implications for timing of implantable cardioverter-defibrillator implantation
78. Adiponectin as an Independent Predictor of the Presence and Degree of Hepatic Steatosis in the Dallas Heart Study
79. Physical activity participation, health perceptions, and cardiovascular disease mortality in a multiethnic population: The Dallas Heart Study
80. Temporal Changes in Body Fat Distribution and Hypertension
81. Potential of Electron Beam Computed Tomography for Coronary Artery Calcium Screening to Evaluate Fatty Liver: Comparison With 1H Magnetic Resonance Spectroscopy in the Dallas Heart Study
82. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity
83. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
84. Effects of Empagliflozin Treatment on Glycerol‐Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial
85. Body Size Misperception: A Novel Determinant in the Obesity Epidemic
86. Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function
87. Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
88. Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study
89. Application of the Screening for Heart Attack Prevention and Education Task Force Recommendations to an Urban Population: Observations From the Dallas Heart Study
90. Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events
91. Racial Differences in Cardiovascular Biomarkers in the General Population
92. Characterization and Trajectory of Coronary Artery Calcium Percentiles: The Dallas Heart Study
93. Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors
94. Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity Among Ambulatory Patients With Type 2 Diabetes Mellitus
95. Abstract P410: Predictive Value of Coronary Artery Calcium for Coronary versus Stroke Events
96. Delayed febrile response with bloodstream infections in patients with continuous-flow left ventricular assist devices
97. A Multimodality Strategy for Cardiovascular Risk Assessment: Performance in Two Population-Based Cohorts
98. Association Between Bendopnea and Key Parameters of Cardiopulmonary Exercise Testing in Patients With Advanced Heart Failure
99. Impact of bendopnea on postoperative outcomes in patients with severe aortic stenosis undergoing aortic valve replacement
100. Abstract 170: Deep Phenotyping of HDL Particles: Characterization of Seven HDL Species and Their Relationship to Cardiometabolic Phenotypes in a Multi-Ethnic Population (Dallas Heart Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.